Search Ontology: 
        
        ChEBI
            prostaglandin D2
- Term ID
 - CHEBI:15555
 - Synonyms
 - 
    
        
        
- (5Z,13E)-(15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate
 - (5Z,13E,15S)-9alpha,15-dihydroxy-11-oxoprosta-5,13-dien-1-oic acid
 - (5Z,13E,15S)-9alpha,15-Dihydroxy-11-oxoprosta-5,13-dienoate
 - 11-Dehydroprostaglandin F2-alpha
 - PGD2
 - Prostaglandin D2
 
 - Definition
 - A member of the class of prostaglandins D that is prosta-5,13-dien-1-oic acid substituted by hydroxy groups at positions 9 and 15 and an oxo group at position 11 (the 5Z,9alpha,13E,15S- stereoisomer).
 - References
 - 
    
        
        
    
    
- CAS:41598-07-6
 - DrugBank:DB02056
 - HMDB:HMDB0001403
 - KEGG:C00696
 - LIPID_MAPS_instance:LMFA03010004
 - PDBeChem:PG2
 - PMID:15843042
 - PMID:24298012
 - PMID:24447364
 - PMID:24456221
 - Reaxys:2170623
 - Wikipedia:Prostaglandin_D2
 
 - Ontology
 - ChEBI ( EBI )
 - Resources
 - CTD
 
                
                    
                        Phenotype 
                    
                    
                
                
            
        
        
    
        
            
            
    
    
    
    
                
                    
                        Phenotype resulting from prostaglandin D2
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype where environments contain prostaglandin D2
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype modified by environments containing prostaglandin D2
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Phenotype affecting prostaglandin D2
                    
                    
                
                
            
        
        
    
        
            
                
            
        
    
    
    
                
                    
                        Human Disease Model